(Q43552562)

24 November 2017

title

Pretreatment of HL60 cells with Deoxyspergualin enhances trail-induced apoptosis independent of caspase 3 activation (English)

1 reference

24 November 2017

J Wu

1

1 reference

24 November 2017

J He

2

1 reference

24 November 2017

S Sooudi

3

1 reference

24 November 2017

X L Jiang

4

1 reference

24 November 2017

P Ray

5

1 reference

24 November 2017

F Thomas

6

1 reference

24 November 2017

J M Thomas

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Transplantation Proceedings

24 November 2017

published in

1 reference

24 November 2017

volume

33

1 reference

24 November 2017

issue

1-2

1 reference

24 November 2017

page(s)

278

1 reference

15-Deoxyspergualin: a novel immunosuppressive drug with clinical potential

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902789-5

7 January 2021

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902789-5

7 January 2021

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902789-5

7 January 2021

TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902789-5

7 January 2021

10.1016/S0041-1345(00)02789-5

Identifiers

DOI

1 reference

24 November 2017

1 reference